Colleagues from across SCRI network will share research insights with oncology leaders from around the globe.
If you are member of the media who is interested in speaking with an expert from SCRI, please contact Becca.Gelman@scri.com.
will present “H3B-6545 in Women with Locally Advanced/Metastatic Estrogen Receptor-Positive, HER2 Negative Breast Cancer” in an oral presentation during the Breast Cancer – Metastatic Rapid Oral Abstract Session on Monday, June 3 from 11:30 a.m. - 1:00 p.m. CDT in Hall D1.
will deliver “Association of MammaPrint Index and 3-Year Outcome of Patients with HR+HER2- Early-Stage Breast Cancer Treated with Chemotherapy with or without Anthracycline” in an oral presentation during the Breast Cancer—Local/Regional/Adjuvant Rapid Oral Abstract Session on Friday, May 31 from 2:45 p.m. - 4:15 p.m. CDT in E451.
will give the oral presentation, “Baseline Characteristics and Efficacy Endpoints for Patients with Node-Negative HR+/HER2− Early Breast Cancer: NATALEE Trial” on Friday, May 31 from 2:45 p.m. - 4:15 p.m. CDT in E451 during the Breast Cancer—Local/Regional/Adjuvant Rapid Oral Abstract Session.
will discuss “ADRIATIC: Durvalumab as Consolidation Treatment for Patients with Limited-Stage Small-Cell Lung Cancer” in an oral presentation during the Plenary Session on Sunday, June 2 from 1:00 p.m. - 4:00 p.m. CDT in Hall B1.
will present “5-Year Multicenter Analysis of Clinical Trial Participation and Total Cost of Care for Older Adults with Cancer” in an oral presentation during the Quality Care/Health Services Research Rapid Oral Abstract Session on Monday, June 3 from 1:15 p.m. -2:45 p.m. CDT in S102.
We hope to see you in person at the 2024 ASCO® Annual Meeting. Visit SCRI at Booth #11058 to speak with our colleagues and research leaders. Our research experts will be available at the booth, check out the calendar.
Learn More About the Power of The SCRI Network from Our Experts.
